CALL
Hamilton & Associates Law Group, P.A.
Securities Law, Exchange Listing and Going Public

Guide to Preparing SEC Form S-1 – A Comprehensive Step-by-Step Overview for Companies Going Public

A Form S-1 registration statement is the central disclosure document used by many companies that want to register securities with the Securities and Exchange Commission and enter the U.S. public markets. It is used in traditional initial public offerings, direct public offerings, selling stockholder resale registrations, certain reverse-merger and uplisting structures, and other registered offerings when another Securities Act registration form is not available or appropriate.

Preparing Form S-1 is not simply a drafting exercise. It is a due diligence project, an audit project, a governance project and a disclosure controls project. The registration statement must describe the company, the securities, the offering, the risk factors, the financial condition of the issuer, the intended use of proceeds, the ownership structure, executive compensation, related-party transactions, material contracts, litigation, dilution, and the plan for distributing the securities.

For many private companies, the S-1 process is the first time management, auditors, securities counsel and directors must build a public-company disclosure record. The quality of that record can affect the length of the SEC review process, the ability to close an offering, the confidence of investors, the success of a Nasdaq, NYSE or OTC Markets pathway, and the company’s post-effective reporting obligations.

Quick Answer: How Do Companies Prepare Form S-1?

A company preparing Form S-1 should begin by deciding the type of transaction it is pursuing, engaging PCAOB-registered auditors and experienced securities counsel, cleaning up its corporate records and capitalization table, organizing material contracts and related-party agreements, preparing audited financial statements, drafting Regulation S-K disclosure, filing through EDGAR, responding to SEC comments and then requesting effectiveness when all staff comments have been resolved.

A practical Form S-1 workflow usually includes the following steps:

  • Confirm the going-public structure, such as IPO, direct public offering, resale registration or uplisting-related registration.
  • Prepare PCAOB-audited financial statements and any required interim, pro forma or acquired-business financial statements.
  • Review the issuer’s articles, bylaws, board approvals, stock issuances, convertible securities, warrants, options, debt instruments and transfer agent records.
  • Draft the prospectus and Part II disclosure using Regulation S-K and Regulation S-X requirements.
  • Build a complete exhibit index with material contracts, organizational documents, legal opinions and auditor consents.
  • File the registration statement on EDGAR and coordinate responses to SEC comment letters.
  • File amendments on Form S-1/A until the SEC review is cleared.
  • Request effectiveness, complete the offering and prepare for ongoing Exchange Act reporting.

What Is Form S-1?

Form S-1 is a Securities Act registration statement used to register securities for public sale. It is broad and flexible, which is why it is commonly used when a company is not eligible to use a shorter registration form. The registration statement contains a prospectus that will be delivered or made available to investors and a Part II section that provides additional information to the SEC, including undertakings, exhibits and recent unregistered securities sales.

The purpose of Form S-1 is to provide material information that allows investors to evaluate the issuer and the securities being offered. It is not an SEC endorsement of the company, the offering price or the securities. The SEC staff reviews filings for compliance with disclosure requirements, accounting requirements and clarity, but the company and the participants involved in the filing remain responsible for complete and accurate disclosure.

Form S-1 is commonly used for:

  • Initial public offerings in which the company sells newly issued shares.
  • Direct public offerings in which securities are sold without a firm-commitment underwriter.
  • Resale registrations for selling stockholders.
  • Registered offerings by issuers that do not qualify for Form S-3.
  • Going-public transactions following certain reverse mergers or reorganizations.
  • Uplisting strategies where an issuer must register securities or become fully SEC reporting before applying for a national exchange or OTC Markets tier.

A company should distinguish Form S-1 from other public-company forms. Form 10 registers a class of securities under the Exchange Act and does not register a public sale of securities. Regulation A uses Form 1-A and has different eligibility, offering size, state law and ongoing reporting rules. Form F-1 is used by many foreign private issuers. Form S-3 is a shorter registration form available only to certain seasoned issuers that meet eligibility requirements. Choosing the correct form should be part of the transaction planning process before counsel starts drafting.

Form S-1 Is Built on Regulation S-K, Regulation S-X and the Company’s Due Diligence Record

A well-prepared S-1 combines three separate workstreams.

First, the narrative disclosure is driven mainly by Regulation S-K. Regulation S-K supplies the disclosure items for the business description, risk factors, MD&A, executive compensation, beneficial ownership, related-party transactions, securities description, use of proceeds, selling security holders, plan of distribution, exhibits and other non-financial disclosure.

Second, the financial statements and certain financial statement schedules are prepared under Regulation S-X. Depending on the issuer’s status and transaction history, the filing may need audited annual financial statements, unaudited interim financial statements, pro forma financial statements, financial statements of an acquired business, or additional schedules. The financial statement requirements are often the most time-sensitive part of the process because stale financial statements can delay the filing or require an amendment before effectiveness.

Third, the S-1 must be supported by a due diligence record. Every disclosure should trace back to underlying documents, board approvals, financial records, contracts, corporate actions or management analysis. A registration statement that sounds polished but is not backed by a clean record is more likely to draw SEC comments, auditor issues, underwriter diligence concerns and investor questions.

Step 1: Choose the Going-Public Structure Before Drafting

The Form S-1 should be drafted around the transaction the issuer is actually pursuing. An IPO, a direct public offering and a resale registration can all use Form S-1, but they require different emphasis.

In a traditional IPO, the prospectus usually reflects an underwritten offering, a proposed exchange listing, preliminary price range, underwriting discounts and commissions, lock-up arrangements, road show considerations and post-IPO capitalization. The company will also need to coordinate with underwriters, exchange listing counsel, auditors and printers or EDGAR service providers.

In a direct public offering, the issuer may sell securities directly to investors or through a best-efforts arrangement. The plan of distribution should clearly explain who will offer the securities, how subscription documents will be processed, whether there is a minimum or maximum offering amount, how proceeds will be held, and when investor funds can be released.

In a resale registration, the company may not receive proceeds from sales by selling stockholders. The selling stockholder table, relationships with the issuer, prior issuances, Rule 144 status, lock-ups, distribution methods and potential underwriter issues become especially important.

In a reverse-merger or uplisting context, Form S-1 often requires heightened attention to shell-company history, historical issuances, promoters, control persons, related-party transactions, legacy convertible notes, prior financing arrangements and whether the company has implemented public-company governance and disclosure controls.

Step 2: Start the PCAOB Audit Early

The audit is usually the longest lead-time item in a Form S-1 project. The company should engage a PCAOB-registered accounting firm early and confirm that the auditor is independent, familiar with SEC financial statement requirements and able to support the expected filing timeline.

Financial statements in an S-1 typically include audited annual financial statements and unaudited interim financial statements. The exact periods required depend on the issuer’s reporting status, filer status, transaction structure, age of the company and other facts. Emerging growth companies and smaller reporting companies may qualify for scaled disclosure in certain circumstances, but issuers should confirm the applicable rules with counsel and auditors before assuming reduced requirements apply.

Audit preparation should include a review of:

  • Revenue recognition and customer contracts.
  • Stock-based compensation, options, warrants and valuation support.
  • Convertible notes, derivative liabilities and embedded conversion features.
  • Related-party transactions, founder loans and expense reimbursements.
  • Going concern analysis and liquidity disclosures.
  • Acquisitions, divestitures and reorganizations.
  • Inventory, reserves and impairment analyses.
  • Tax matters, deferred tax assets and valuation allowances.
  • Segment reporting and key business metrics.
  • Internal control weaknesses and remediation plans.

Companies frequently underestimate how much work is required to reconstruct private-company accounting records into public-company financial statements. If the issuer has changed accountants, acquired a business, reorganized subsidiaries, issued multiple classes of securities, used complicated debt instruments or operated without formal controls, the audit timeline should be planned conservatively.

Step 3: Clean Up Corporate Records, Governance and the Capitalization Table

Before filing Form S-1, the company should be able to explain and document its corporate history. The SEC staff, auditors, underwriters, investors and market participants may scrutinize the issuer’s capitalization, governance history and legal structure.

A corporate cleanup process should include:

  • Confirming the issuer’s charter, bylaws and amendments are current and consistent.
  • Reviewing board and shareholder approvals for all securities issuances.
  • Reconciling transfer agent records to the company’s capitalization table.
  • Reviewing options, warrants, convertible notes, SAFEs and preferred stock rights.
  • Confirming vesting schedules, exercise prices, conversion formulas and anti-dilution provisions.
  • Reviewing employment agreements, consulting agreements and equity incentive plans.
  • Confirming intellectual property assignments from founders, employees and contractors.
  • Reviewing leases, loans, vendor contracts, customer agreements and licensing arrangements.
  • Identifying related-party transactions and conflicts of interest.
  • Reviewing litigation, regulatory matters and threatened claims.
  • Assessing board independence, committee structure and code of ethics considerations.

A clean capitalization table is especially important. Problems with undocumented issuances, missing board approvals, inconsistent legends, convertible note disputes, toxic financing provisions or unresolved transfer agent issues can delay the S-1 and create disclosure issues. For companies seeking a Nasdaq or NYSE listing, public-company governance requirements should be considered before the first filing, not after SEC comments have been received.

Step 4: Draft a Consistent Equity Story Across the Prospectus

The best S-1 filings are internally consistent. The summary, business section, MD&A, risk factors, financial statement notes, use of proceeds and plan of distribution should tell the same story from different angles.

The prospectus summary introduces the company and the offering. The business section explains the company’s operations, products, markets, strategy, customers, suppliers, competition, intellectual property, human capital and regulatory environment. MD&A explains the financial side of the story, including revenue drivers, expenses, liquidity, capital resources, trends and uncertainties. Risk factors explain the material reasons the investment is speculative or risky. The financial statements and notes supply the audited record behind the narrative.

If one section describes a major customer concentration, the risk factors and MD&A should address the potential impact. If MD&A discusses dependence on future financing, the risk factors and use of proceeds should be consistent. If the business section highlights artificial intelligence, cybersecurity, regulated products or major contracts, the risk factors, legal proceedings, IP disclosure and financial statement notes should be reviewed for consistency.

SEC comments often arise when sections of the S-1 appear disconnected. A common example is a business section that promotes rapid growth while MD&A shows declining revenue or recurring losses without adequate explanation. Another example is a risk factor that says the company may need additional financing when MD&A already shows a current liquidity deficiency. A third example is financial statement notes describing related-party balances that are not discussed in the related-party transaction section.

Step 5: Understand Each Part of Form S-1

Form S-1 is divided into Part I, which contains information required in the prospectus, and Part II, which contains information not required in the prospectus. The following section provides a practical item-by-item guide for drafting.

Part I Item 1: Cover Page and Forepart of the Registration Statement

The cover page is one of the most visible parts of the filing. It should identify the issuer, the securities offered, the number of securities, the anticipated offering price or price range when available, the proposed trading market or exchange, the ticker symbol if known, the underwriters or placement agents if any, and basic offering terms.

Before effectiveness, a preliminary prospectus typically includes a subject-to-completion legend that makes clear the registration statement is not yet effective and that securities cannot be sold until effectiveness. In an IPO, some information may be blank at initial filing because pricing, final share count and underwriting details may not be available until later in the process. When the company begins marketing the offering, the preliminary prospectus should include a bona fide price range if required.

The cover page should also alert investors to important structural features, such as:

  • Dual-class voting structures.
  • Controlled-company status.
  • Emerging growth company or smaller reporting company status.
  • Lack of an existing public market.
  • Listing contingencies.
  • Underwriter over-allotment options.
  • Risk factor cross-references.
  • State securities law or jurisdictional limitations, where relevant.

Because the cover page is short, every sentence should be deliberate. Avoid trying to place the entire equity story on the cover page. Use it to communicate key offering facts and legally required information in plain English.

Part I Item 2: Inside Front and Outside Back Cover Pages

This section covers additional prospectus legends, dealer delivery language, table of contents placement and similar front and back cover disclosure. For many issuers, these items are handled through standard prospectus language. Even so, the legends should be checked carefully because they can vary depending on whether the prospectus is preliminary or final, whether the securities will be listed, whether the offering is underwritten, whether the offering is being made outside the United States, and whether the issuer is using free writing prospectuses or testing-the-waters materials.

Part I Item 3: Summary Information and Risk Factors

The prospectus summary should give investors a concise overview of the company, the offering and the most important reasons investors may be interested in the securities. It should not simply repeat the business and MD&A sections. It should highlight the issuer’s business model, strategy, market opportunity, key risks, summary financial information, capitalization, use of proceeds and offering terms.

A strong summary answers basic investor questions quickly:

  • What does the company do?
  • How does it generate revenue?
  • What market does it serve?
  • What are the company’s core growth strategies?
  • What securities are being offered?
  • Will the company receive proceeds?
  • What will the proceeds be used for?
  • What major risks should investors consider before investing?

The risk factor section is one of the most important parts of Form S-1. Risk factors should focus on material risks that make an investment in the company or the offering speculative or risky. Each risk factor should be specific to the company and should explain how the risk could affect the issuer or the securities. Generic risks that could apply to any company should be avoided or moved to the end under a general risk heading if they are included at all.

Effective risk factor drafting should address:

  • Company-specific operational risks.
  • Industry and regulatory risks.
  • Revenue concentration and customer dependency.
  • Supplier dependency and manufacturing risks.
  • Liquidity, debt and future financing risks.
  • Going concern and working capital risks.
  • Cybersecurity, data privacy and artificial intelligence risks where applicable.
  • Intellectual property risks.
  • Litigation and regulatory enforcement risks.
  • Risks related to acquisitions and integration.
  • Risks related to material weaknesses in internal control.
  • Control person, dual-class voting or insider ownership risks.
  • Risks related to penny stock rules, thin trading or lack of public market.
  • Risks associated with resale offerings and selling stockholder overhang.

The most useful risk factors are not merely labels. For example, it is not enough to say that competition could harm the business. The disclosure should explain the nature of the competition, the company’s current competitive position, whether competitors have greater resources, whether pricing pressure exists, and how those facts could affect revenue, margins or growth.

Part I Item 4: Use of Proceeds

Use of proceeds disclosure should explain how the issuer intends to use the money raised in the offering. If the company will use proceeds for working capital, product development, sales and marketing, hiring, debt repayment, acquisitions or facility expansion, the prospectus should provide meaningful detail.

When proceeds will repay debt, the company should describe the debt, interest rate, maturity, use of the original proceeds and whether the debt is owed to related parties. When proceeds may be used for acquisitions, the disclosure should state whether the company has any current agreements, commitments or understandings. If the issuer has no specific plan for part of the proceeds, the disclosure should explain that fact without overstating certainty.

Overly broad phrases such as “general corporate purposes” may be acceptable only when supported by more specific context. The goal is to let investors understand whether offering funds will finance growth, repay insiders, support operations, extend runway or restructure the balance sheet.

Part I Item 5: Determination of Offering Price

The determination of offering price section explains how the offering price was established. In an underwritten IPO, the price is often determined through negotiations between the company and the underwriters based on market conditions, investor demand, comparable companies, financial condition, business prospects and other factors.

In a direct public offering or self-underwritten offering, the company should explain the basis for the price. This can include the company’s financial condition, book value, market comparisons, recent private financings, valuation analysis, expected business prospects or other relevant factors. If there is no existing public market, that fact should be clear.

Part I Item 6: Dilution

Dilution disclosure shows the difference between the price paid by new investors and the net tangible book value per share after the offering. It helps investors understand how much immediate dilution they may experience if they purchase securities in the offering.

The dilution section should clearly identify the assumptions used in the calculation. These assumptions may include the offering price, number of shares offered, underwriting discounts, estimated offering expenses, conversion of preferred stock, exercise or exclusion of options and warrants, and whether selling stockholder shares are included. If the company has convertible securities, preferred stock, warrants or a large equity incentive plan, the disclosure should be reviewed carefully so investors understand potential future dilution.

Part I Item 7: Selling Security Holders

Selling security holder disclosure is required when securities are being registered for resale. The table should identify each selling stockholder, the number of shares beneficially owned before the offering, the number of shares offered, and the number or percentage of shares that will be owned after the offering if all registered shares are sold.

The company should also disclose material relationships with selling stockholders, including whether a selling stockholder is an affiliate, officer, director, promoter, broker-dealer, affiliate of a broker-dealer, consultant, investor in a prior private placement or party to a material agreement. The history of the securities being registered should be documented, including issuance dates, exemption relied upon and consideration paid.

Selling stockholder disclosure is especially important in resale S-1 filings because the company may not receive any proceeds from resale sales. If the transaction involves convertible notes, warrants, equity lines, standby equity purchase agreements or other financing structures, the disclosure should explain how many shares may be issued and registered and whether the selling stockholder could create market overhang.

Part I Item 8: Plan of Distribution

The plan of distribution explains how the securities will be offered and sold. This section differs significantly depending on the transaction structure.

For an underwritten IPO, the plan of distribution will describe the underwriting agreement, underwriting discounts and commissions, over-allotment option, lock-up agreements, stabilization activities, offering restrictions and the role of the underwriters. For a direct public offering, it may describe subscription procedures, escrow arrangements, best-efforts terms, minimum or maximum offering amounts and the role of officers, directors or placement agents. For a resale registration, it should describe the methods selling stockholders may use to sell shares, including brokerage transactions, market transactions, negotiated transactions or other permitted methods.

The plan of distribution should be drafted carefully because ambiguous distribution language can raise broker-dealer, underwriter and state securities law questions. Issuers should avoid saying or implying that securities will trade immediately after effectiveness unless the company has addressed the separate market-making, Form 211, exchange listing or OTC Markets requirements applicable to its pathway.

Part I Item 9: Description of Securities to Be Registered

The description of securities section explains the legal rights of the securities being offered. For common stock, this usually includes voting rights, dividend rights, liquidation rights, preemptive rights, conversion rights, redemption rights, transfer restrictions and anti-takeover provisions. For preferred stock, warrants, units, debt securities or convertible securities, the description should be tailored to the governing instruments.

The disclosure should be consistent with the issuer’s charter, bylaws, certificate of designation, warrant agreement, note instrument, subscription agreement and other governing documents. If the company has dual-class stock, blank-check preferred stock, super-voting shares, automatic conversion rights, protective provisions, registration rights, transfer restrictions or anti-dilution rights, those features should be described clearly.

This section should not be treated as boilerplate. Investors need to understand what they are buying and how their rights compare with insiders, preferred stockholders, warrant holders and other classes of security holders.

Part I Item 10: Interests of Named Experts and Counsel

The registration statement must disclose certain interests of experts and counsel named in the prospectus. For example, if a named expert, auditor or legal counsel has a direct or indirect interest in the issuer’s securities or will receive contingent compensation, the disclosure should be analyzed. In many filings, this section is short, but it should not be ignored.

Part I Item 11: Information With Respect to the Registrant

Item 11 is the heart of Form S-1. It pulls in many of the most important Regulation S-K disclosures, including business, property, legal proceedings, market information, financial statements, MD&A, accountant changes, market risk, directors and officers, executive compensation, beneficial ownership, related-party transactions and corporate governance.

Business Description

The business section should provide a complete and balanced description of the company. It may discuss the issuer’s history, mission, products, services, technology, customers, suppliers, sales and marketing strategy, distribution channels, manufacturing, intellectual property, research and development, regulatory environment, competition, seasonality, human capital, material contracts and facilities.

Although the business section can present the company’s strengths and strategy in a positive manner, it must be grounded in supportable facts. Market opportunity claims should be supported by reliable data or a clearly explained methodology. Customer wins, growth rates, partnerships, technical capabilities and product performance claims should be reviewed against contracts, records and financial statements.

A useful business section often includes:

  • A concise overview of what the company does.
  • A description of the problem the company addresses.
  • The company’s products, services or platform.
  • Revenue model and pricing structure.
  • Target customers and sales channels.
  • Competitive landscape and competitive strengths.
  • Intellectual property and proprietary technology.
  • Regulatory matters and required permits or approvals.
  • Human capital and key employees.
  • Material contracts and strategic relationships.
  • Facilities and property.
  • Legal proceedings and contingent liabilities, if material.

Property Disclosure

The property section should describe material properties owned or leased by the company. For many operating companies, this may include headquarters, manufacturing sites, laboratories, warehouses, retail facilities or leased offices. For mining, oil and gas, real estate, cannabis, manufacturing and other asset-heavy issuers, property disclosure can be much more detailed and may require specialized technical or regulatory input.

Legal Proceedings

The legal proceedings section should describe material pending legal proceedings, proceedings known to be contemplated by government authorities and certain environmental matters. This disclosure should be reconciled with financial statement contingencies, board minutes, counsel letters, risk factors and MD&A. Litigation that appears immaterial from a damages perspective may still be material if it affects licenses, operations, key contracts, reputation or the ability to complete the offering.

Market Price, Dividends and Related Stockholder Matters

If the issuer has common equity securities outstanding, the S-1 should address market information, dividend policy and related stockholder matters. A company with no public market should state that clearly. If the company does not expect to pay dividends, it should explain that earnings, if any, are expected to be retained for operations and growth, subject to board discretion and legal limitations.

MD&A

Management’s Discussion and Analysis is one of the most heavily reviewed sections of Form S-1. MD&A should give investors management’s view of the company’s financial condition, cash flows, results of operations, liquidity, capital resources, known trends and uncertainties.

MD&A should not merely repeat the financial statements. It should explain why results changed, what drove revenue or margin movement, what caused expenses to increase or decrease, whether trends are expected to continue, whether liquidity is sufficient, and what known events could materially affect the company’s future financial condition.

A strong MD&A typically includes:

  • Overview of the business and recent developments.
  • Key factors affecting performance.
  • Revenue drivers and customer or product trends.
  • Cost of revenue, gross margin and operating expense analysis.
  • Period-to-period comparisons with quantitative and qualitative explanations.
  • Liquidity and capital resources, including cash runway and financing plans.
  • Known commitments, debt obligations and capital expenditure plans.
  • Going concern discussion, if applicable.
  • Critical accounting estimates.
  • Key performance indicators that management uses to run the business.
  • Non-GAAP financial measures, if used, with appropriate GAAP prominence and reconciliation.
  • Segment or geographic disclosure where necessary.

Issuers should be cautious with non-GAAP metrics. If non-GAAP measures are included, the filing should present the most comparable GAAP measure with equal or greater prominence, reconcile the measures and explain why management believes the non-GAAP measure is useful. Companies should also consider whether metrics disclosed in the IPO or S-1 process will create expectations for future quarterly and annual reporting.

Changes in and Disagreements With Accountants

If the company changed auditors or had disagreements with accountants on accounting or financial disclosure, the S-1 should include the required disclosure and exhibits. Auditor changes can draw SEC comments when disclosure is incomplete, inconsistent with prior filings or missing the former auditor’s letter.

Market Risk

Market risk disclosure may be required if the company has material exposure to interest rates, foreign currency, commodity prices or other market-sensitive instruments. Smaller companies sometimes overlook this item, but it should be analyzed when the issuer has debt, investments, international operations, foreign currency revenue, crypto assets, commodity exposure or derivative instruments.

Directors, Executive Officers and Corporate Governance

The S-1 should identify directors, executive officers and significant employees where applicable. Biographical disclosure should cover business experience, relevant qualifications, family relationships and certain legal proceedings during the required lookback period. The company should review whether any director or officer has been involved in bankruptcy, criminal proceedings, securities law injunctions, bars, suspensions or similar proceedings requiring disclosure.

Corporate governance disclosure should address board composition, independence, committees, audit committee financial expert disclosure, code of ethics, leadership structure and related governance matters. Nasdaq and NYSE applicants should coordinate S-1 disclosure with exchange governance requirements well before listing.

Executive Compensation

Executive compensation disclosure should be prepared carefully because it combines legal requirements, accounting inputs and governance decisions. The required level of detail depends on whether the company is a smaller reporting company, emerging growth company or larger issuer. Scaled disclosure may be available for qualifying issuers, but compensation tables and narrative explanations still must be accurate.

The S-1 should address compensation paid to named executive officers, salary, bonus, stock awards, option awards, non-equity incentive compensation, all other compensation, employment agreements, severance, change-in-control arrangements, equity plans and director compensation. If founders or executives receive personal benefits, related-party payments, aircraft use, security arrangements, consulting fees, housing, reimbursements or payments to affiliated entities, counsel and auditors should analyze whether disclosure is required.

Security Ownership of Certain Beneficial Owners and Management

The beneficial ownership table shows the equity ownership of directors, officers, named executive officers, 5% holders and selling stockholders where applicable. The table should be prepared using beneficial ownership principles, not merely record ownership. Options, warrants, convertible securities and voting agreements may affect the calculation.

The company should reconcile the ownership table to the transfer agent list, option ledger, warrant schedule, note schedule, charter, shareholder agreements and selling stockholder table. If the offering changes ownership percentages, both pre-offering and post-offering ownership should be calculated based on clear assumptions.

Related-Party Transactions

Related-party transactions are a common SEC comment area, particularly for smaller issuers, founder-led companies and reverse-merger companies. The S-1 should disclose transactions with directors, officers, nominees, significant stockholders, immediate family members and entities affiliated with related persons when disclosure thresholds and materiality standards are met.

Examples include founder loans, consulting agreements, leases with affiliates, shared services, advances, debt guarantees, asset transfers, employment of family members, payments to entities controlled by insiders, private placements involving affiliates, and transactions with promoters or control persons. The disclosure should describe the relationship, transaction terms, amounts involved, balances outstanding and whether the company has a policy for review and approval of related-party transactions.

Part I Item 12 and Item 11A: Incorporation by Reference and Material Changes

Certain eligible registrants may incorporate information by reference into Form S-1. Many first-time issuers and going-public companies will not be eligible. If incorporation by reference is available, the company should confirm eligibility carefully and ensure that incorporated documents are current, available and accurately identified.

If the company uses incorporation by reference, it may also need to describe material changes in the registrant’s affairs that have occurred since the end of the latest fiscal year covered by audited financial statements and that have not been disclosed in Exchange Act reports.

Part I Item 12A: Commission Position on Indemnification

Form S-1 requires disclosure of the SEC’s position on indemnification for Securities Act liabilities. This is usually included near the indemnification disclosure and undertakings. The issuer should coordinate the disclosure with its charter, bylaws, indemnification agreements and applicable state corporate law.

Part II: Information Not Required in the Prospectus

Part II contains additional information filed with the SEC but not typically included in the investor-facing prospectus. Companies should not treat Part II as an afterthought. Missing exhibits, incomplete recent sales disclosure or incorrect undertakings can delay effectiveness.

Item 13: Other Expenses of Issuance and Distribution

This item estimates the expenses of the offering, including SEC filing fees, FINRA filing fees if applicable, exchange listing fees, accounting fees, legal fees, transfer agent fees, printing or EDGAR fees, blue sky fees and miscellaneous expenses. The amounts may be estimated, but they should be reasonable and updated as necessary.

Item 14: Indemnification of Directors and Officers

This disclosure describes indemnification available under state law, the company’s charter and bylaws, indemnification agreements and directors and officers insurance. It should be reviewed against the company’s governing documents and applicable law.

Item 15: Recent Sales of Unregistered Securities

Recent sales disclosure should identify securities sold without registration, typically during the prior three years, including the date of sale, title and amount of securities, purchasers or classes of purchasers, consideration received and exemption relied upon. This section should reconcile to the capitalization table, board approvals, subscription agreements, note instruments, warrant agreements and transfer records.

For companies that raised capital through multiple private placements, convertible notes, consultant issuances or founder issuances, Item 15 can become lengthy. Accuracy matters because inconsistencies can raise questions about Securities Act compliance and whether shares were properly issued.

Item 16: Exhibits and Financial Statement Schedules

The exhibit index should be built early and updated throughout the drafting process. Required exhibits may include:

  • Certificate or articles of incorporation and amendments.
  • Bylaws and amendments.
  • Form of common stock certificate, warrant certificate or unit certificate.
  • Underwriting, placement agency, subscription or escrow agreements.
  • Voting agreements, investor rights agreements and registration rights agreements.
  • Material contracts not made in the ordinary course of business.
  • Employment agreements and equity incentive plans.
  • Loan agreements, convertible notes and security agreements.
  • Leases and licenses that are material to operations.
  • Legal opinion regarding the securities being registered.
  • Auditor consent.
  • Power of attorney.
  • Subsidiary list, where required.
  • Filing fee table exhibits.

Material contracts should be reviewed for confidential information, termination provisions, exclusivity, minimum purchase commitments, change-of-control clauses and disclosure consistency. If an issuer omits confidential information from a material contract exhibit under applicable rules, it should follow the redaction and marking requirements carefully.

Item 17: Undertakings

Undertakings are required commitments included in the registration statement. They can vary depending on the type of offering, Rule 415 status, incorporation by reference, indemnification and other features. Issuers should use the undertakings applicable to their offering and avoid blindly copying undertakings from unrelated filings.

SEC Review of Form S-1

After Form S-1 is filed on EDGAR, it is reviewed by the SEC’s Division of Corporation Finance. The staff may conduct a full review, financial statement review or targeted issue review depending on the filing and circumstances. In the S-1 context, companies should expect the staff to focus on whether the registration statement complies with disclosure rules, whether the financial statements comply with accounting requirements, and whether the disclosure is clear, complete and internally consistent.

The staff may issue a comment letter requesting that the company provide supplemental information, revise the disclosure, add disclosure, explain accounting treatment or make changes in future filings. The company typically responds with a letter and files an amendment on Form S-1/A showing revised disclosure. The staff may issue additional comments after reviewing the response and amendment.

Common S-1 comment areas include:

  • Generic or overly broad risk factors.
  • MD&A that does not explain period-to-period changes.
  • Missing known trends, uncertainties or liquidity discussion.
  • Insufficient disclosure of related-party transactions.
  • Inconsistent share numbers across the filing.
  • Missing selling stockholder information.
  • Incomplete plan of distribution disclosure.
  • Unsupported market opportunity claims.
  • Non-GAAP measures presented more prominently than GAAP measures.
  • Missing exhibits or auditor consents.
  • Financial statement staleness or missing pro forma financials.
  • Legal proceedings not reconciled with risk factors and contingencies.
  • Unclear use of proceeds.
  • Inadequate dilution calculations.
  • Vague descriptions of the company’s actual business operations.

The first SEC comment letter often arrives several weeks after filing, but timing depends on the nature of the filing, staff workload, complexity of the issuer, accounting issues and whether the filing is an initial public offering, resale registration or other transaction. Many companies experience multiple rounds of comments before the registration statement is cleared for effectiveness.

How to Respond to SEC Comments Efficiently

A disciplined comment response process can reduce delays. The company should read each comment carefully, identify the staff’s concern, assign responsibility to counsel, auditors or management, prepare revised disclosure where appropriate, and respond directly.

A good response letter should:

  • Quote or summarize each SEC comment before the response.
  • State where responsive disclosure has been added or revised.
  • Provide supplemental analysis when the company believes no change is required.
  • Avoid argumentative tone.
  • Reconcile responses with changes made elsewhere in the filing.
  • Coordinate accounting responses with the audit firm.
  • Keep a control copy of all changed pages and supporting materials.

If the company does not understand a comment, counsel may seek clarification from the SEC staff. It is usually better to clarify early than to file an amendment that does not address the staff’s concern. Companies should also remember that comment letters and responses generally become public after the review process is complete, so responses should be professional, accurate and drafted with future public availability in mind.

Financial Statements and MD&A Should Be Updated Throughout the Process

S-1 preparation does not stop after the first filing. Financial statements may become stale, interim periods may need to be added, subsequent events may require disclosure, and MD&A may need to be refreshed. If the company experiences material developments during the review process, the filing may need to be amended.

Events that can require updates include:

  • Completion of a financing.
  • Entry into or termination of a material contract.
  • Closing of an acquisition or disposition.
  • New litigation or regulatory action.
  • Material revenue changes.
  • Debt defaults or covenant issues.
  • Significant cybersecurity incidents.
  • Changes in directors, officers or auditors.
  • Stock splits, recapitalizations or charter amendments.
  • Changes to offering size, price range or use of proceeds.

A company should maintain a disclosure committee or equivalent internal process during the S-1 review period to capture material developments before they become amendment problems.

Preparing for Effectiveness

When the SEC staff has no further comments, the company may request that the registration statement be declared effective. Before making that request, counsel should confirm that the filing includes current financial statements, signed audit reports, required consents, final or near-final exhibits, correct filing fee tables, complete undertakings and accurate offering information.

For an IPO, the company and underwriters will coordinate pricing, underwriting agreement execution, exchange approval, closing mechanics and final prospectus filing. For a direct public offering, the company will coordinate subscription acceptance, escrow or proceeds release, state law matters and investor delivery of the final prospectus. For a resale registration, the company will coordinate effectiveness notices, prospectus delivery obligations, selling stockholder instructions and any transfer agent procedures.

Effectiveness does not automatically create an active trading market. A company may still need exchange approval, FINRA processing, a market maker, Form 211 review, DTC eligibility, OTC Markets applications, transfer agent coordination or other post-effective steps depending on the transaction.

Post-Effective Obligations After Form S-1

After Form S-1 is declared effective, the issuer may become subject to ongoing reporting obligations. Depending on its status, the company may need to file annual reports on Form 10-K, quarterly reports on Form 10-Q, current reports on Form 8-K, proxy statements, beneficial ownership reports and Section 16 reports by insiders.

Public-company readiness should therefore begin before filing the S-1. Companies should establish disclosure controls, accounting calendars, board committees, insider trading policies, Regulation FD policies, whistleblower procedures, related-party transaction policies and controls over press releases and investor communications.

A company that treats the S-1 as the end of the process may struggle after effectiveness. The better approach is to use the S-1 process to build the systems necessary for life as a public company.

Common Form S-1 Mistakes to Avoid

1. Beginning the Audit Too Late

The audit should start before the first full draft of the registration statement. Waiting until the disclosure is nearly complete can create bottlenecks, especially if the auditors identify revenue recognition issues, missing documentation, stock compensation valuation problems or related-party balances.

2. Using Boilerplate Risk Factors

Risk factors should be specific to the issuer. The SEC staff routinely questions risks that do not explain how a particular risk affects the company. A biotech company, fintech company, software company, manufacturer, mining company and cannabis company should not have interchangeable risk factor sections.

3. Failing to Reconcile the Cap Table

Share counts appear throughout the S-1, including the cover page, capitalization, dilution, selling stockholder table, beneficial ownership table, financial statements, description of securities and exhibit schedules. Inconsistent share counts are easy for reviewers to spot and can undermine confidence in the filing.

4. Underdisclosing Related-Party Transactions

Private companies often have informal founder arrangements, affiliate loans, shared services, leases, expense advances and consulting agreements. These should be identified early and analyzed for disclosure.

5. Overpromoting the Business Section

The business section may tell the company’s story, but it should not make claims that cannot be supported. Avoid exaggerated market opportunity statements, unsupported superlatives, vague technology claims and predictions that are not properly framed.

6. Treating MD&A as a Narrative Version of the Financial Statements

MD&A should explain the reasons behind the numbers. It should discuss known trends, uncertainties and liquidity matters from management’s perspective. Repeating the income statement in paragraph form is not enough.

7. Presenting Non-GAAP Metrics Without Proper Context

Non-GAAP measures can be useful, but they must be presented carefully. The filing should include the comparable GAAP measure, reconciliation, explanation of usefulness and balanced presentation.

8. Filing an Incomplete Exhibit Index

Missing material contracts, legal opinions, auditor consents or filing fee exhibits can prevent effectiveness. Build the exhibit index early and assign responsibility for each exhibit.

9. Ignoring Post-Effective Trading Requirements

An effective S-1 does not by itself guarantee a trading market. Companies pursuing OTC Markets or exchange listings should coordinate the S-1 with market maker, Form 211, DTC, transfer agent and listing requirements.

10. Forgetting That SEC Comment Letters Become Public

The company’s responses to SEC comments can be reviewed later by investors, plaintiffs, analysts, competitors and regulators. Responses should be accurate, complete and consistent with the public filing.

Form S-1 Preparation Checklist

Before filing Form S-1, the company should be able to answer the following questions:

  • Has the company selected the correct registration form and transaction structure?
  • Are the financial statements current and PCAOB-audited where required?
  • Are interim financial statements needed?
  • Are any pro forma or acquired-business financial statements required?
  • Has the company reconciled its capitalization table to transfer agent records?
  • Have all stock issuances been approved and documented?
  • Have convertible notes, warrants and options been analyzed?
  • Are related-party transactions identified and quantified?
  • Are material contracts collected and reviewed for exhibit filing?
  • Are risk factors tailored to the company and the offering?
  • Does MD&A explain known trends, liquidity and period-to-period changes?
  • Is the use of proceeds specific and consistent with the company’s cash needs?
  • Is dilution calculated correctly?
  • Is the selling stockholder table complete, if applicable?
  • Does the plan of distribution match the actual offering structure?
  • Are directors, officers and compensation disclosures complete?
  • Are beneficial ownership calculations accurate?
  • Are litigation and regulatory matters reconciled with financial statement contingencies?
  • Are legal opinions, auditor consents and powers of attorney ready?
  • Has the company obtained EDGAR access codes?
  • Has the company planned for Exchange Act reporting after effectiveness?

Frequently Asked Questions About Form S-1

What is SEC Form S-1?

SEC Form S-1 is a registration statement used by companies to register securities for public sale under the Securities Act of 1933. It includes a prospectus for investors and additional information filed with the SEC.

Is Form S-1 only for IPOs?

No. Form S-1 is commonly used for IPOs, but it can also be used for direct public offerings, resale registrations, registered offerings by non-seasoned issuers and certain going-public or uplisting strategies.

What is the difference between Form S-1 and Form 10?

Form S-1 registers securities for public sale under the Securities Act. Form 10 registers a class of securities under the Exchange Act and generally makes the company subject to reporting obligations, but it does not register a sale of securities.

What is Regulation S-K?

Regulation S-K is the SEC’s primary set of non-financial disclosure requirements for registration statements and reports. Form S-1 relies on Regulation S-K for many key sections, including business, risk factors, MD&A, executive compensation, security ownership, related-party transactions, use of proceeds, plan of distribution and exhibits.

What financial statements are required in Form S-1?

The required financial statements depend on the issuer’s status, age, transaction history and applicable Regulation S-X requirements. Most S-1 filings require audited annual financial statements and unaudited interim financial statements. Some issuers may also need pro forma financial statements or financial statements of acquired businesses.

Does the audit need to be performed by a PCAOB-registered firm?

For an issuer filing a registration statement with the SEC, the audit should be performed by an independent public accounting firm registered with the PCAOB and qualified to issue an audit report included in an SEC filing.

How long does the Form S-1 process take?

The timeline depends on audit readiness, corporate cleanup, transaction complexity, SEC comments and the company’s responsiveness. Many companies spend months preparing the audit and first filing, then go through one or more rounds of SEC comments and amendments before effectiveness.

What is Form S-1/A?

Form S-1/A is an amendment to a previously filed Form S-1. Companies file amendments to update disclosure, respond to SEC comments, add financial statements, revise offering terms, include exhibits or make other changes before effectiveness.

What are common SEC comments on Form S-1?

Common comments focus on risk factor specificity, MD&A trends and liquidity, revenue recognition, related-party transactions, selling stockholder disclosure, dilution, use of proceeds, plan of distribution, non-GAAP measures, missing exhibits and financial statement requirements.

Can a company sell securities immediately after filing Form S-1?

No. Securities registered on Form S-1 generally cannot be sold until the registration statement is declared effective by the SEC. Preliminary prospectuses may be used in permitted ways before effectiveness, but sales must wait until effectiveness.

Does an effective Form S-1 guarantee Nasdaq, NYSE or OTC trading?

No. Effectiveness of Form S-1 and trading eligibility are separate matters. A company may still need exchange approval, FINRA processing, a sponsoring market maker, Form 211 clearance, OTC Markets approval, DTC eligibility or other steps depending on its trading pathway.

Conclusion

Preparing Form S-1 is one of the most important steps in the going-public process. A strong registration statement does more than satisfy a checklist. It presents the company’s business, risks, financial condition, capitalization, governance, offering terms and securities in a way that is complete, accurate, consistent and understandable to investors.

Companies that plan early, complete PCAOB audits, clean up corporate records, document securities issuances, draft tailored Regulation S-K disclosure, prepare a complete exhibit index and respond carefully to SEC comments are better positioned for a smoother review process. Whether the issuer is pursuing an IPO, direct public offering, resale registration, reverse-merger cleanup or uplisting strategy, experienced securities counsel and qualified auditors are essential to a successful Form S-1 process.

Hamilton & Associates Law Group, P.A. assists issuers with Form S-1 registration statements, SEC comments, going-public transactions, Nasdaq and NYSE listings, OTC Markets matters, direct public offerings, resale registrations and ongoing public-company compliance. Companies considering a registered offering should begin planning well before the desired filing date so audit, disclosure, governance and market-entry issues can be addressed before they delay the transaction.


To speak with a Securities Attorney, please contact Brenda Hamilton at 200 E Palmetto Rd, Suite 103, Boca Raton, Florida, (561) 416-8956, or by email at [email protected].

Hamilton & Associates | Securities Attorneys
Brenda Hamilton, Securities Attorney
200 E Palmetto Rd, Suite 103
Boca Raton, Florida 33432
Telephone: (561) 416-8956
Facsimile: (561) 416-2855
www.SecuritiesLawyer101.com

Copyright © 2026 · All Rights Reserved · Hamilton & Associates Law Group, P.A.